Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more
Oncoclinicas do Brasil (ONCO3) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.127x
Based on the latest financial reports, Oncoclinicas do Brasil (ONCO3) has a cash flow conversion efficiency ratio of 0.127x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$151.75 Million) by net assets (R$1.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oncoclinicas do Brasil - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Oncoclinicas do Brasil's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oncoclinicas do Brasil Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncoclinicas do Brasil ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amata VN PCL
BK:AMATAV
|
0.044x |
|
Renova Energia S.A
SA:RNEW11
|
0.000x |
|
Advtech
JSE:ADH
|
0.311x |
|
Nosa Med AB
ST:NOSA
|
-0.054x |
|
Jing-Jan Retail Business Co., Ltd.
TWO:2942
|
0.044x |
|
Duta Intidaya Tbk PT
JK:DAYA
|
-0.595x |
|
Kesoram Industries Limited
NSE:KESORAMIND
|
-0.150x |
|
Econergy Renewable Energy Ltd
TA:ECNR
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Oncoclinicas do Brasil (2013–2024)
The table below shows the annual cash flow conversion efficiency of Oncoclinicas do Brasil from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$3.38 Billion | R$-184.85 Million | -0.055x | -183.98% |
| 2023-12-31 | R$2.68 Billion | R$-51.56 Million | -0.019x | +81.35% |
| 2022-12-31 | R$2.63 Billion | R$-271.64 Million | -0.103x | -2462.19% |
| 2021-12-31 | R$2.30 Billion | R$-9.28 Million | -0.004x | -102.81% |
| 2020-12-31 | R$681.17 Million | R$97.56 Million | 0.143x | -3.16% |
| 2019-12-31 | R$656.37 Million | R$97.08 Million | 0.148x | +78.93% |
| 2018-12-31 | R$470.12 Million | R$38.86 Million | 0.083x | -85.80% |
| 2017-12-31 | R$232.44 Million | R$135.26 Million | 0.582x | +787.30% |
| 2016-12-31 | R$244.56 Million | R$-20.71 Million | -0.085x | -435.49% |
| 2015-12-31 | R$195.87 Million | R$-3.10 Million | -0.016x | -103.88% |
| 2014-12-31 | R$22.77 Million | R$9.29 Million | 0.408x | +167.53% |
| 2013-12-31 | R$48.16 Million | R$7.34 Million | 0.152x | -- |